
    
      Each patient received two successive IV antibiotic courses during a period of pulmonary
      exacerbation. One of these courses was delivered as thrice daily 30-minute infusions of
      ceftazidime in 100 ml of 0.9% sodium chloride, and the other was delivered as a continuous
      infusion of ceftazidime in 230 ml of 0.9% sodium chloride, over 23 hours. The daily dose of
      ceftazidime was 200 mg/kg, with a maximum dose of 12 g. For ceftazidime continuous infusion,
      a loading dose of 60 mg/kg (maximum 2 g) was used. All patients also received tobramycin (10
      mg/kg), in the form of one 30-minute infusion per day. Portable devices were used: Intermate®
      SV 200 (Baxter) for the 30-minute short infusions of ceftazidime and tobramycin, Infusor®
      LV10 (Baxter) for continuous infusion of ceftazidime.
    
  